Clinical & Translational Oncology

Papers
(The TQCC of Clinical & Translational Oncology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation 86
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma62
Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance60
Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinic46
Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy38
Comparative genomic characterization of melanoma of known and unknown primary37
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view36
Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression36
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers36
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)33
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways28
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects26
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA26
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis25
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer25
SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain24
Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non-small-cell lung cancer22
Low-dose radiation therapy for hand osteoarthritis: shaking hands again?22
Complex roles of discoidin domain receptor tyrosine kinases in cancer20
Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience20
Characterization of a xenograft model for anti-CD19 CAR T cell studies19
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review19
Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis18
A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma18
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types18
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia17
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis17
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivati17
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)17
Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level17
Del-1 enhances therapeutic efficacy of bacterial cancer immunotherapy by blocking recruitment of tumor-infiltrating neutrophils17
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus16
Immunotherapy in AML: a brief review on emerging strategies16
Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway16
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)16
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis15
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy15
Targeting GLS1 to cancer therapy through glutamine metabolism14
Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol14
SEOM clinical guideline for management of adult medulloblastoma (2020)14
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab13
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients13
Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs)13
Overall survival for early and locally advanced non-small-cell lung cancer from one institution: 2000–201713
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain13
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma13
0.087604999542236